What is NDC 13668-446?

13668-446 is the product NDC for Rasagiline, Rasagiline mesylate 1 mg/1 tablet, listed with the FDA by Torrent Pharmaceuticals Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Torrent Pharmaceuticals Limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rasagiline?

26 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rasagiline NDC 13668-446 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)13668-446Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13668-0446Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
13668-446-05	1366804460513668044605	500 TABLET in 1 CONTAINER (13668-446-05)Marketed from Nov 15, 2025
13668-446-30	1366804463013668044630	30 TABLET in 1 CONTAINER (13668-446-30)Marketed from Nov 15, 2025
13668-446-90	1366804469013668044690	90 TABLET in 1 CONTAINER (13668-446-90)Marketed from Nov 15, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rasagiline
Generic name (nonproprietary): rasagiline
Active ingredients: Rasagiline mesylate — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Torrent Pharmaceuticals LimitedNDC labeler code 13668
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210150
Marketing start: Nov 15, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Monoamine Oxidase Inhibitors (Mechanism)
Identifiers: Product ID 13668-446_fa1b2a7e-f459-4432-97f2-23d2c07c2dacSPL ID fa1b2a7e-f459-4432-97f2-23d2c07c2dacSPL set ID 2c5e3cde-1158-4b5a-9a2b-ea6c987a65e4RxCUI 608328, 636664UNII LH8C2JI290
Pharmacologic class: Monoamine Oxidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413668044605 followed by a unit qualifier and the quantity

Package 13668-0446-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 11, 2026.

Indications (excerpt from the label)

Rasagiline tablets are indicated for the treatment of Parkinson's disease (PD). Rasagiline Tablets, a monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson's disease ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 13668-446

What is NDC 13668-446?: 13668-446 is the product NDC for Rasagiline, Rasagiline mesylate 1 mg/1 tablet, listed with the FDA by Torrent Pharmaceuticals Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rasagiline.
What is the active ingredient?: Rasagiline mesylate.
Who is the labeler?: Torrent Pharmaceuticals Limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rasagiline?: 26 other product NDCs are listed under this name. See all Rasagiline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rasagiline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rasagiline	Rasagiline mesylate 1 mg/1	TabletOral	REMEDYREPACK INC.	70518-4735	70518-4735-0070518-4735-01
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4683	70518-4683-00
Rasagilinerasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	Carnegie Pharmaceuticals LLC	80005-141	80005-0141-0880005-0141-1080005-0141-14
Rasagilinerasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	Carnegie Pharmaceuticals LLC	80005-142	80005-0142-0880005-0142-1080005-0142-14
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	Torrent Pharmaceuticals Limited	13668-447	13668-0447-0513668-0447-3013668-0447-90
Rasagilinerasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-711	64980-0711-30
Rasagilinerasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-712	64980-0712-30
Rasagilinerasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	SKG Pharma Inc.	83085-007	83085-0007-1083085-0007-3083085-0007-50
Rasagilinerasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	SKG Pharma Inc.	83085-008	83085-0008-1083085-0008-3083085-0008-50
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-308	33342-0308-07

All 27 Rasagiline NDCs

Other NDCs under ANDA 210150

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210150
Product	Strength	Form · route	Labeler	Product NDC
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	Torrent Pharmaceuticals Limited	13668-447